General Practice Doctors in Fpo, AA Accepting Medicare

4 General Practice doctors found. Showing 1 - 4

Michael Gedestad, DO General Practice Medicare: Not Enrolled in Medicare Practice Location: 34800 Bob Wilson Dr., Fpo, AA 92134 Phone: 619-532-6400

Alexis Brittany Cross, DO General Practice Medicare: Not Enrolled in Medicare Practice Location: 4494 Palmer Rd N, Fpo, AA 20814 Phone: 301-295-4000

Dr. Tammy Elizabeth Servies, MD General Practice Medicare: Medicare Enrolled Practice Location: Psc 1005 Box 11185, Fpo, AA 34009 Phone: 757-458-2998

Dr. Scott Gerald Story, M.D. General Practice Medicare: Medicare Enrolled Practice Location: Navy Military Support Cmd: Attn: Medical Staff Services, Bldg H 2005 Knight Lane, Jacksonville, Fl, Fpo, AA 32212 Phone: 619-532-6684

News Archive

CVS Caremark announces results of Consent Solicitation from registered holders

CVS Caremark Corporation announced today the results of its previously announced solicitation of consents from the registered holders as of 5:00 p.m., New York City time on August 8, 2011 of its 6.125% Senior Notes due August 15, 2016 to terminate the replacement capital covenant, which was entered into on May 25, 2007, for the benefit of the holders of the Notes in connection with the issuance of its 6.302% Enhanced Capital Advantaged Preferred Securities due 2062.

Brain scans of newborn babies made available online to advance research

The Developing Human Connectome Project has published ground-breaking MR brain scans of over 500 newborn babies, which researchers from all over the world can download and use to study how the human brain develops.

QIAGEN, Epigenomics enter option agreement to commercialize colorectal cancer blood test

Epigenomics AG, the cancer molecular diagnostics company, and QIAGEN today announced that the companies have entered into an option agreement allowing QIAGEN to develop and, should QIAGEN exercise the option, commercialize a colorectal cancer blood test based on Epigenomics' proprietary biomarker mSEPT9 and certain DNA methylation analysis technologies.

Eylea receives Health Canada approval for treatment of CRVO and DME

Bayer Inc. announced today that it has received approval from Health Canada for Eylea (aflibercept, solution for intravitreal injection) for the treatment of diabetic macular edema (DME). This new indication comes just six weeks following the October 16th approval of Eylea for the treatment of visual impairment due to macular edema secondary to central retinal vein occlusion (CRVO).

Read more Medical News

› Verified 8 days ago